List of insiders holdings for CORCEPT THERAPEUTICS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | Tammenoms Bakker Juliet 10% Owner |
2016-12-19 13:29:28 | 133,539 10,956,002 |
11,089,541 | Form 4 |
2 | ANDERSON DAVID L Former 10% Owner |
2013-02-13 20:10:23 | 0 6,420,729 |
6,420,729 | Form 5 |
3 | YOUNGER WILLIAM H JR Former 10% Owner |
2013-02-13 20:24:40 | 0 6,333,795 |
6,333,795 | Form 5 |
4 | COXE TENCH Former 10% Owner |
2013-02-13 19:47:54 | 0 6,317,984 |
6,317,984 | Form 5 |
5 | GAITHER JAMES C Former 10% Owner |
2013-02-13 19:27:32 | 37,002 5,508,259 |
5,545,261 | Form 5 |
6 | BAKER G LEONARD JR Director |
2025-01-02 18:03:46 | 1,046,631 4,263,565 |
5,310,196 | Form 4 |
7 | SUTTER HILL VENTURES BAKER G LEONARD JR ANDERSON DAVID L YOUNGER WILLIAM H JR COXE TENCH GAITHER JAMES C SWEET DAVID E SHEEHAN ANDREW T Speiser Michael L BIRD JEFFREY W 10% Owner |
2016-02-16 14:22:06 | 4,505,527 0 |
4,505,527 | Form 13G |
8 | SUTTER HILL VENTURES WHITE JAMES N 10% Owner |
2016-02-16 14:22:06 | 4,505,527 0 |
4,505,527 | Form 13G |
9 | BELANOFF JOSEPH K Chief Executive Officer |
2025-04-02 20:01:10 | 0 2,981,985 |
2,981,985 | Form 4 |
10 | SCHATZBERG ALAN F Director 10% Owner |
2008-01-31 11:31:16 | 2,738,749 0 |
2,738,749 | Form 13G |
11 | ALTA BIOPHARMA PARTNERS II LP MARDUEL ALIX DELEAGE JEAN CHAMPSI FARAH ALTA BIOPHARMA MANAGEMENT II LLC ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC ALTA PARTNERS II INC 10% Owner |
2011-02-03 15:34:10 | 2,641,076 0 |
2,641,076 | Form 13G |
12 | ALTA BIOPHARMA PARTNERS II LP ALTA BIOPHARMA MANAGEMENT II LLC ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC ALTA PARTNERS II INC DELEAGE JEAN CHAMPSI FARAH 10% Owner |
2011-02-03 15:34:10 | 2,641,076 0 |
2,641,076 | Form 13G |
13 | ALTA BIOPHARMA PARTNERS II LP ALTA CALIFORNIA MANAGEMENT PARTNERS II LLC ALTA EMBARCADERO PARTNERS II LLC DELEAGE JEAN CHAMPSI FARAH ALTA PARTNERS II INC 10% Owner |
2011-02-03 15:34:10 | 2,641,076 0 |
2,641,076 | Form 13G |
14 | WILSON JAMES N Director |
2025-01-29 16:14:00 | 0 2,346,235 |
2,346,235 | Form 4 |
15 | Longitude Venture Partners L.P. Longitude Capital Partners LLC Tammenoms Bakker Juliet Longitude Capital Associates L.P. 10% Owner |
2017-06-13 16:15:39 | 2,344,998 0 |
2,344,998 | Form 13D |
16 | BERNAL RONALD D 10% Owner |
2005-02-01 20:02:48 | 0 2,298,834 |
2,298,834 | Form 3 |
17 | Loewy Caroline M Chief Financial Officer |
2008-12-02 11:57:33 | 800,000 0 |
800,000 | Form 4 |
18 | SINGER DAVID B Director |
2008-02-13 16:47:15 | 726,669 66,998 |
793,667 | Form 5 |
19 | Lo Steven SVP Oncology |
2015-11-16 18:21:06 | 585,416 0 |
585,416 | Form 4 |
20 | Maduck Sean See Remarks |
2025-04-02 20:20:03 | 507,018 20,000 |
527,018 | Form 4 |
21 | Guyer William Chief Development Officer |
2025-04-02 20:08:27 | 454,809 0 |
454,809 | Form 4 |
22 | ENRIGHT PATRICK G Director |
2017-03-20 16:36:22 | 272,281 114,675 |
386,956 | Form 4 |
23 | FISHMAN ROBERT S Chief Medical Officer |
2018-11-09 17:06:30 | 329,000 0 |
329,000 | Form 4 |
24 | Pullara Samuel J III 10% Owner |
2013-07-10 20:15:08 | 0 280,365 |
280,365 | Form 3/A |
25 | Dyckerhoff Stefan A 10% Owner |
2013-07-10 20:12:04 | 0 280,365 |
280,365 | Form 3/A |
26 | SANDS GREGORY P 10% Owner |
2011-10-25 18:01:31 | 23,889 246,043 |
269,932 | Form 4 |
27 | PENHOET EDWARD 10% Owner |
2010-04-06 20:12:15 | 41,250 180,204 |
221,454 | Form 4 |
28 | Harper James A Director |
2010-07-12 17:03:38 | 209,900 7,500 |
217,400 | Form 4 |
29 | Paperboy Ventures LLC Director |
2009-05-11 17:42:40 | 209,694 0 |
209,694 | Form 4 |
30 | ROE ROBERT L President and Secretary |
2013-02-01 19:26:03 | 200,000 0 |
200,000 | Form 4 |
31 | Grauer Andreas Chief Medical Officer |
2021-02-08 17:15:30 | 200,000 0 |
200,000 | Form 4 |
32 | Lyon Joseph Douglas See Remarks |
2025-04-02 20:15:27 | 171,501 0 |
171,501 | Form 4 |
33 | Mokari Atabak Chief Financial Officer |
2025-03-04 19:34:41 | 153,034 0 |
153,034 | Form 4 |
34 | Hunt Hazel Chief Scientific Officer |
2025-03-04 19:38:54 | 140,000 0 |
140,000 | Form 4 |
35 | BRADBURY DANIEL Director |
2019-02-12 21:44:18 | 0 130,575 |
130,575 | Form 4 |
36 | LeDoux Anne M VP & Controller |
2015-09-29 18:30:30 | 125,000 0 |
125,000 | Form 4 |
37 | ANDERSSON ALLEN Director |
2009-06-29 14:02:01 | 0 97,143 |
97,143 | Form 4/A |
38 | TURNER JOSEPH L Director |
2015-06-23 15:03:19 | 50,000 0 |
50,000 | Form 4/A |
39 | Park Kimberly Director |
2024-05-21 18:47:35 | 30,000 0 |
30,000 | Form 4 |
40 | Murray Joshua M. Director |
2024-05-21 18:42:49 | 30,000 0 |
30,000 | Form 4 |
41 | Alton Gregg H Director |
2024-05-21 18:30:14 | 30,000 0 |
30,000 | Form 4 |
42 | MAHONEY DAVID L Director |
2024-05-21 18:28:53 | 30,000 0 |
30,000 | Form 4 |
43 | Cannon Gillian Director |
2024-05-21 18:25:15 | 30,000 0 |
30,000 | Form 4 |
44 | COOK JOSEPH C JR Director |
2015-06-22 21:53:28 | 30,000 0 |
30,000 | Form 4 |
45 | Robb Gary Charles Chief Business Officer |
2025-03-24 20:30:38 | 18,865 10,898 |
29,763 | Form 4 |
46 | GALA RENEE D Director |
2018-08-22 17:38:48 | 25,000 0 |
25,000 | Form 4 |
47 | KURLAND FRED Chief Financial Officer |
2006-03-06 18:22:12 | 25,000 0 |
25,000 | Form 4 |
48 | Swisher Daniel N JR Director |
2025-04-14 17:58:11 | 1,800 0 |
1,800 | Form 4 |
49 | KAPP STEVEN Director |
2004-04-14 16:04:07 | 0 0 |
0 | Form 3 |